Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability and Proliferation Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) uses WST-8, a water-soluble tetrazolium salt, for highly sensitive quantification of viable cell number in vitro (APExBIO, product page). WST-8 reduction by cellular dehydrogenases produces a water-soluble formazan dye, directly correlating absorbance to viable cell count in as little as 1–4 hours. CCK-8 outperforms legacy MTT, XTT, and MTS assays in sensitivity, convenience, and compatibility with high-throughput workflows (Kuang et al., 2025). The kit is validated for cancer, neurodegeneration, and metabolic disease models, especially under oxidative stress. APExBIO’s CCK-8 (SKU K1018) is optimized for reproducibility in multi-well plate formats. CCK-8 is not suitable for measuring non-metabolically active or apoptotic cells with severely impaired mitochondrial function.

Biological Rationale

Reliable measurement of cell viability underpins research in oncology, neurodegeneration, drug screening, and tissue engineering (Kuang et al., 2025). Many disease processes, including osteoarthritis, involve changes in cell proliferation, apoptosis, and metabolic activity. For example, reactive oxygen species (ROS) drive cartilage degeneration in temporomandibular joint osteoarthritis (TMJOA), where cell loss and oxidative stress co-occur. Quantitative assessment of cell viability or cytotoxicity enables precise evaluation of pharmacological interventions, such as disease-modifying osteoarthritis drugs (DMOADs), and mechanistic studies of cell signaling pathways. Water-soluble tetrazolium salt-based cell viability assays, such as CCK-8, are preferred for their minimal cytotoxicity and compatibility with multiplexed readouts, overcoming limitations of older, insoluble formazan-based methods (See here for protocol guidance). This article extends existing content by detailing the molecular rationale for WST-8’s selectivity and benchmarking CCK-8’s reliability in oxidative stress models.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 employs WST-8, a tetrazolium salt that is reduced by cellular dehydrogenases in metabolically active (viable) cells. The reduction reaction produces a water-soluble formazan dye, with absorbance measurable at 450 nm. The amount of dye formed is directly proportional to the number of living cells present. This reaction occurs in the presence of an electron mediator (1-methoxy PMS), facilitating electron transfer from NADH/NADPH-dependent enzymes to WST-8. The water solubility of the product eliminates the need for solubilization steps required in MTT assays, reducing assay time and variability (APExBIO CCK-8 product page). The mechanism relies on intact mitochondrial and cytosolic dehydrogenase activity, which is diminished in dying or apoptotic cells (cf. mechanistic review). This section clarifies the unique bioreduction pathway that distinguishes CCK-8 from other colorimetric assays.

Evidence & Benchmarks

• CCK-8 (WST-8) achieves linear quantification of viable cells from 5 × 10² to 1 × 10⁵ cells/well in 96-well plates (manufacturer protocol, APExBIO).
• In a TMJOA model, CCK-8 was used to quantify chondrocyte proliferation and cytotoxicity after hydrogel and FGF18 treatment, providing time-course resolution at multiple experimental endpoints (Kuang et al., 2025).
• CCK-8 signal is stable for at least 4 hours post-reaction, allowing flexible readout scheduling and minimizing timing artifacts (APExBIO, product page).
• Compared to MTT, CCK-8 yields higher signal-to-background ratios and requires no solubilization step, reducing hands-on time by at least 30% (see review).
• WST-8 formazan is non-cytotoxic, permitting subsequent downstream analyses or multiplexed assays in the same wells (protocol guide).
• CCK-8 sensitivity enables detection of mitochondrial dehydrogenase inhibition by ROS or cytotoxic drugs, making it suitable for oxidative stress screening (Kuang et al., 2025).

Applications, Limits & Misconceptions

CCK-8 is broadly used in cell proliferation, cytotoxicity, and viability assays, particularly in cancer and metabolic research. The kit reliably detects changes in cell number in response to drugs, genetic perturbations, or environmental stressors. It is validated for use with adherent and suspension cell lines, primary cultures, and tissue explants. CCK-8 is especially valuable for high-throughput screening, where its single-step protocol and low cytotoxicity minimize workflow complexity. This article clarifies the mechanistic boundaries of the CCK-8 reaction, especially for users transitioning from legacy assays (see translational review).

Common Pitfalls or Misconceptions

• Not suitable for non-metabolically active cells: Cells with very low or absent dehydrogenase activity (e.g., late-stage apoptotic or necrotic cells) will not produce a WST-8 signal.
• Assay readout can be confounded by reducing agents: Exogenous antioxidants or high serum concentrations may artificially increase background signal.
• Not a direct measure of cell death: CCK-8 quantifies metabolic activity; some cytostatic drugs reduce proliferation without causing cell death, which can complicate interpretation.
• Signal saturation at high cell densities: Above 1 × 10⁵ cells/well, signal may plateau due to substrate depletion.
• WST-8 is light sensitive: Prolonged exposure to strong light may degrade reagent and decrease sensitivity.

Workflow Integration & Parameters

For typical 96-well plate assays, add 10 μL of CCK-8 reagent per 100 μL of cell culture medium, incubate for 1–4 hours at 37°C, and read absorbance at 450 nm. The water-soluble formazan product allows direct measurement without additional processing. CCK-8 is compatible with phenol red-containing media and does not require medium change prior to addition. For drug screening, CCK-8 can be multiplexed with fluorescent or luminescent readouts. The kit supports endpoint and kinetic measurements, enabling real-time monitoring of cell responses. APExBIO’s K1018 kit provides batch-validated performance and is recommended for reproducibility in multi-well formats (see product).

This article extends prior content by clarifying the lower detection threshold and real-time assay adaptability, updating the protocol details described in this guide.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) represents a robust, sensitive platform for cell viability and proliferation assays across biomedical research domains. Its water-soluble WST-8 chemistry enables direct, quantitative assessment of viable cell number and is validated in models of oxidative stress, cancer, and tissue engineering. APExBIO’s CCK-8 (K1018) outperforms legacy MTT-type assays in sensitivity, workflow simplicity, and compatibility with downstream analyses. As precision medicine and high-throughput phenotypic screening expand, CCK-8’s reliability and adaptability will become increasingly important. Researchers are advised to select CCK-8 for applications requiring sensitive, reproducible cell viability data—especially when tracking subtle metabolic changes under experimental treatments.

For full specifications and lot validation, visit the APExBIO CCK-8 product page.